Principal Investigator
Bernard Baumel
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240984
Clinical Trial Summary
A Pilot Study to Assess the Effect of Adding 1 Infusion of Human Mesenchymal Stem Cells (hMSC) to the Treatment of Patients Suffering Agitation/Aggression or Other Behavioral Abnormalities from Alzheimers Disease.
Phase
Phase II
Funding Agency/Sponsor
Intramural
Disease
Memory Disorders
Contact Information
Study Contact
Maria Puertas Rosales
Phone Number
+1 (305) 2433100
Email
mep980@miami.edu